ISRG
Not a rating change, but definitely a wink
Evercore ISI’s Vijay Kumar left Intuitive Surgical at In Line with a $480 price target, but added the stock to the firm’s Tactical Outperform List. Translation: it’s not a full-blown upgrade, but it is a pretty loud “we like this into earnings” gesture.
Why the timing matters
The note comes right before tomorrow’s Q1 earnings report, and that’s where the real fireworks could be. Kumar is betting procedure growth stays sturdy enough to give ISRG a pop, with the possibility of a 200-basis-point beat on the metric short-term traders are obsessing over.
The stock’s already telling a story
ISRG has spent the last year bouncing between $450 and $600, and it’s currently hanging out near the lower end of that range. So if earnings land better than expected, this could be one of those “the setup was there all along” moments investors love to pretend they saw coming.
Big picture
For a company like Intuitive Surgical, the whole game is whether robot-assisted procedures keep humming along. If they do, this kind of pre-earnings vote of confidence can matter more than the label on the rating sheet.